checkAd
    Startseite > Aktien > Molecular Partners > Nachrichten
    Molecular Partners
    Aktie
    ISIN: CH0256379097 WKN: A12DEH Land Schweiz
    Zur Watchlist hinzufügen Zum Portfolio hinzufügen
    5,5750
     
    EUR
    +20,87 %
    +0,9625 EUR
    Letzter Kurs 12.06.24 Lang & Schwarz
    Geldkurs
    12.06.24
    5,5100
     
    EUR
    1.105 STK
    Briefkurs
    12.06.24
    5,6400
     
    EUR
    1.105 STK

    Molecular Partners Aktie kaufen

    Kauf
    Verkauf

    Neueste Nachrichten

    Molecular Partners and Orano Med Share Positive Preclinical Data of their DLL3-Targeting Radio-DARPin Therapy (RDT) Candidate MP0712 at SNMMI 2024
    11.06.24 · globenewswire · Molecular Partners
    Molecular Partners Presents Positive Data From Completed Phase 1 Trial Of MP0317 (FAP X CD40 DARPin) Monotherapy In Patients With Advanced Solid Tumors At ASCO 2024
    01.06.24 · globenewswire · Molecular Partners
    Interim Management Statement Q1 2024 of Molecular Partners: Pipeline Progressing with Two Additional Programs to Enter the Clinic in 2025, Update to MP0533 Program
    16.05.24 · globenewswire · Molecular Partners
    Molecular Partners Announces Publication in Cancer Immunology Research of Preclinical Data Supporting MP0533’s Proposed Mechanism of Action 
    29.04.24 · globenewswire · Molecular Partners
    Life Science Cares Launches in Switzerland
    19.04.24 · globenewswire · Molecular Partners
    Molecular Partners Announces All Board Proposals Approved at the Annual General Meeting
    17.04.24 · globenewswire · Molecular Partners
    Molecular Partners Publishes Invitation to Annual General Meeting 2024
    26.03.24 · globenewswire · Molecular Partners
    Molecular Partners Reports Corporate Highlights From Q4 2023 and Key Financials for Full Year 2023
    14.03.24 · globenewswire · Molecular Partners
    Molecular Partners Announces Dismissal of Class Action Lawsuit
    01.03.24 · globenewswire · Molecular Partners
    Molecular Partners To Hold Conference Call to Discuss Fourth Quarter and Full Year 2023 Results and Announces Upcoming Investor Presentations
    01.03.24 · globenewswire · Molecular Partners
    Molecular Partners Provides Updates at 42nd Annual J.P. Morgan Healthcare Conference
    07.01.24 · globenewswire · Molecular Partners
    Molecular Partners and Orano Med Announce Co-Development Agreement for Radio-DARPin Therapies
    05.01.24 · globenewswire · Molecular Partners